ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 240529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 240529; 2) Community: the network communities that were significantly associated with the response to NSC 240529; 3) Molecule: the relationships between components within communities and NSC 240529; 4) MDR: the compounds that were significantly associated with the NSC 240529.

NSC Compound Enrichment Correlation
NSC 639174 Camptothecin Derivative 0.0100995289754787 0.70707334
NSC 642954 Null 0.0100995289754787 0.26604408
NSC 666586 Null 0.0100995289754787 0.33064181
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.0100995289754787 0.25852245
NSC 672136 9-.alpha.-Hydroxyparthenolide 0.0100995289754787 0.44160392
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.0100995289754787 0.75181543
NSC 678932 1H-Benzimidazole-4-carboxamide, N-[2-(dimethylamino)ethyl]-2-(4-pyridinyl)-, hydrochloride 0.0100995289754787 0.17590463
NSC 680300 Null 0.0100995289754787 0.34500562
NSC 681639 Camptothecin Derivative 0.0100995289754787 0.64881378
NSC 681719 Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl]amino]-, 2,4-dimethyl-3-pentanyl ester 0.0100995289754787 0.38059009
Total:99  Current:28    [First] [Prev] [Next] [Last]